A Phase 2, Randomized, Double-blind, Sham Surgery-controlled Study of the Efficacy and Safety of Intraputaminal AAV2-GDNF in the Treatment of Adults with Moderate Stage Parkinson's Disease. ASK- PD5-CS201,
Role: Investigator,
Asklepios BioPharmaceutical, Inc.,
(04/2026 - 04/2027)
Status: Approved
Internal
MRI Evidence of Increased Iron Deposition in the Basal Ganglia of Patients Admitted for Stroke with a History of Methamphetamine Use: A Prevalence Study,
Role: Investigator,
LLU Dept. of Neurology,
(09/2023)
Status: Approved
Prevalence of Functional Neurological Signs in Parkinson's Disease: A Cross-Sectional Analysis,
Role: Investigator,
LLU Dept. of Neurology,
(05/2026)
Status: Approved